Rio Pharmaceuticals
Manufacturing · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.riopharmaceuticals.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Rio Pharmaceuticals
Rio Pharmaceuticals is a privately held company focused on transforming the diagnosis of neurological diseases through the development of innovative positron emission tomography (PET) imaging technology. Their lead product, RP115, targets the EAAT2 protein in the central nervous system to quantify pathological changes associated with conditions such as Alzheimer's disease and Amyotrophic Lateral Sclerosis. The company is advancing clinical trials in the United States and Australia, aiming to provide clinicians with improved diagnostic capabilities and the ability to monitor disease progression. With support from notable organizations, Rio Pharmaceuticals is committed to bringing novel diagnostic tools to the clinical market.Explore more
Popular SearchesRio Pharmaceuticals IncRio PharmaceuticalsSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rio Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Rio Pharmaceuticals launches new products
Rio Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Rio Pharmaceuticals recently announced quarterly report
Click to see if Rio Pharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Rio Pharmaceuticals
Check if Rio Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Rio Pharmaceuticals has new funding data
Check out if Rio Pharmaceuticals is spiking on competitors!
Recommended Actions
Find VP level buyers at Rio Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Rio Pharmaceuticals
Compare insights from companies similar to Rio Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Rio Pharmaceuticals
<$5M
1-10
Private
-
2008
N/A
Company Profile Activity
Activity Insights
Rio Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rio Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rio Pharmaceuticals.
Rio Pharmaceuticals Tech Stack
A closer look at the technologies used by Rio Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rio Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Rio Pharmaceuticals is a privately held company focused on transforming the diagnosis of neurological diseases through the development of innovative positron emission tomography (PET) imaging technology. Their lead product, RP115, targets the EAAT2 protein in the central nervous system to quantify pathological changes associated with conditions suc... Read More
